CSF for beta amyloid 1-42 & tau
Jump to navigation
Jump to search
Indications
Clinical significance
- CSF from patients with Alzheimer's disease vs control:
| analyte | Alzheimer's disease* | control |
|---|---|---|
| beta-amyloid 1-42: | 183 pg/mL | 491 pg/mL |
| tau: | 587 pg/mL | 244 pg/mL |
false negatives: 8%
false positives: 11%
* Most diagnoses not yet confirmed by autopsy
More general terms
References
- ↑ Journal Watch 23(10):91, 2003 Sutherland T et al, JAMA April 23/30 289:2094, 2003 http://jama.ama-assn.org/cgi/content/full/289/16/2094